Heads Cannabis

Cannabis Blog and Resources

Oregon Bill to Increase Tobacco Age to 21 Passes Senate Committee

An Oregon Senate committee has given approval to legislation that would raise the minimum age for purchasing tobacco and tobacco products to 21.

Senate Bill 754 was passed by the Senate Healthcare Committee with a close 3 to 2 vote, sending it towards a full Senate vote. The measure was filed by a bipartisan coalition of nine senators and state representatives.

The proposed law “Increases from 18 to 21 years old the minimum age to purchase tobacco and nicotine products.” It would establish “a set of fines ranging from $250-$1,000 for individuals or businesses that distribute or sell tobacco-related products or inhalant delivery systems to persons under 21 years of age.”

In addition, the measure “Modifies statutory definition of cigarettes to include inhalant devices and products not approved by the U.S. Food and Drug Administration”, and “Expands the types of facilities not permitted to allow a person under 21 years of age to possess tobacco or inhalant delivery systems when on facility grounds to include colleges, community colleges, universities, career schools and technical education schools.”

Click here for the full text of Senate Bill 754.

About Anthony Martinelli

Anthony, co-founder and Editor-in-Chief of TheJointBlog, has worked closely with numerous elected officials who support cannabis law reform, including as the former Campaign Manager for Washington State Representative Dave Upthegrove. He has also been published by multiple media outlets, including the Seattle Times. He can be reached at TheJointBlog@TheJointBlog.com.


Published at Thu, 23 Mar 2017 22:49:26 +0000

Read More

Stephen Colbert Makes Fun of Jeff Sessions Over Marijuana Comments

On yesterday’s episode of Late Night With Stephen Colbert, Colbert made fun of Sessions’ recent remarks that marijuana is “only slightly less awful” than heroin.

Before responding to Sessions remark, Colbert made a cannabis-related joke within the first two minutes of his opening monologue.

“White House staffers are so afraid that a deep state of career military and intelligence officials are out to destroy them. Now, what is a deep state? I thought a deep state is what you achieve after doing three bong hits and watching Planet Earth? Very deep… very deep. Those lizards are going to get caught by those snakes!”

A few minutes later Colbert asked his audience; “Does anyone dabble in the marijuana?”, which led to heavy cheering from the crowd. “Shh… not so loud” Colbert said. “Don’t tell our attorney general and forest gnome whose riddles are kind of racist Jeff Sessions.”

Colbert then went over Sessions recent comments that marijuana is “only slightly less awful”  than heroin, and responded by saying; “Sure, marijuana’s only slightly less awful than heroin…. like how burning your tongue on hot cocoa is only slightly less awful than being set on fire.”

Following the joke, Colbert said; “Sessions really is uptight, if only there was someway to mellow him out, something that’s legal in half of America at this point.”

Colbert’s comments can be seen in the video below:

About Anthony Martinelli

Anthony, co-founder and Editor-in-Chief of TheJointBlog, has worked closely with numerous elected officials who support cannabis law reform, including as the former Campaign Manager for Washington State Representative Dave Upthegrove. He has also been published by multiple media outlets, including the Seattle Times. He can be reached at TheJointBlog@TheJointBlog.com.


Published at Wed, 22 Mar 2017 21:33:16 +0000

Read More

Cannabis Treatments For Colon Cancer Patients

Cannabis for Colon Cancer

colon cancer and cannabis

The colon, also known as the large intestine, is located in the lowe part of the digestive system. The colon is responsible for removing water and salt from the solid wastes in the body before it passes through the rectum and out the anus. Cancer of the colon is the second biggest cancer killer in both men and women in the United States.

Colon cancer cells grow from noncancerous or benign tumors, also known as adenomatous polyps which settle on the interior of the large intestine. Sometimes, these polyps can become malignant colon cancers if they aren’t removed during colonoscopy, a procedure which examines the condition of the intestine’s inner linings. If cancer cells damage healthy tissue surrounding the tumor, this can cause severe and life-threatening complications.

Colon cancer isn’t the same as rectal cancer although in some cases they occur together and this is known as colorectal cancer. The most common causes of cancer are age, genes, diets, lifestyle and habits. Other medical conditions have been associated with an increased risk for colon cancer: diabetes, radiation, and Crohn’s disease.

During the early stage of colon cancer it’s rare to experience any symptoms. However when the disease progresses, the symptoms include constipation or diarrhea, rectal bleeding, blood in the stool, pain during defecation, unexplained weight loss, fatigue, iron deficiency, and irritable bowel syndrome. If the cancer has spread, more symptoms can present itself where the new cancer cells have grown.

Colon cancer treatments will depend on the kind of cancer, its stage, the patients’ age and health status as well as other personal characteristics. The most common treatment options for colon cancer are surgery (colectomy), chemotherapy, and radiation.

How Can Cannabis Help?


Colon cancer is one of the multitude of cancers that cannabis can help treat, as well as make chemotherapy or radiation treatments more bearable. A study published in the Journal of Molecular Medicine, conducted by researchers from the UK and Italy showed that cannabis extracts that contain high amounts of CBD may aid in the prevention of colon cancer spreading in mice. The “botanical drug substance” used that had high amounts of CBD was successful in inhibiting the growth of tumor cells without affecting healthy cells. The scientists also found that this action was enabled due to the activation of the CB1 and CB2 receptors in the cells.

The study also analyzed the effect of pure CBD on colon cancer. Based on the data collected, pure CBD was effective in activating CB1 receptors which resulted in the prevention of tumor growth. The study’s authors wrote in the report: Although cannabidiol has been shown to kill glioma cells, to inhibit cancer cell invasion and to reduce the growth of breast carcinoma and lung metastases in rodents, its effect on colon carcinogenesis has not been evaluated to date. This is an important omission, since colon cancer affects millions of individuals in Western countries. In the present study, we have shown that cannabidiol exerts (1) protective effects in an experimental model of colon cancer and (2) antiproliferative actions in colorectal carcinoma cells.” In the scientific journal Current Drug Safety, clinical review data was published concluding that CBD is “non-toxic” for healthy cells.


Aside from helping to prevent the spread of cancer, patients with colon cancer and who are undergoing chemotherapy can also benefit from using cannabis. Patients can choose from many ways to incorporate the plant into their cancer treatment regimen. Nausea and vomiting is a common side effect of chemotherapy procedures, and can also lead to appetite loss which will deprive the patient of valuable nutrients needed to speed up their healing. Cannabis can help treat nausea and vomiting, while certain strains can also help induce appetite to help speed up the healing process for patients.

There are many anecdotal cases online of individuals who have been able to successfully treat their colon cancers in different stages using cannabis. More studies need to be conducted although this has been a huge hurdle even if CBD isn’t psychoactive because federal law states that it’s still illegal. Once there is more information on cannabis as well as the other valuable cannabinoids and their impact on colon cancer, the plant can be used to save even more lives.








Published at Sun, 19 Mar 2017 05:00:00 +0000

Read More

Maple Leaf Seeks New $6M Financing and Terminates Previous Offering

Maple Leaf Green World (MGW-V) intends to raise up to CAD $6 million in capital by way of a non-brokered private placement to accredited investors. The proposed private placement consists of an offering of up to 11 million units at a subscription price of $0.55per unit, each unit being comprised of one common share and one common share purchase warrant.

Each warrant issuable in connection with the offering will be exercisable at a price of $0.85 for a period of two years after closing. The minimum subscription for the offering is 19,000 units. Although the private placement is non-brokered, Maple Leaf reserves the right to pay finder’s fees in connection with the Offering. Any securities issued pursuant to this offering will be subject to restrictions on resale for a specified period of not less than four months after closing.

The company intends to use the net proceeds of the offering for the Company’s medical marijuana project in Canada and for working capital. This non-brokered private placement is subject to review and acceptance by the TSX Venture Exchange.

The company wishes to confirm it will not be proceeding with its proposed non-brokered private placement of $5 million at $0.70 per unit (first announced on February 7, 2017) due to, among other things, recent positive changes in prospects of its ACMPR application in Canada.

Third lawsuit launched against Mettrum over tainted cannabis

A Nova Scotia man has joined the ranks of people suing licensed producers over pesticide-laden pot, adding more questions about Health Canada’s claim that people who consumed the tainted products were safe from harm.

The latest proposed class action is against Mettrum and is led by Halifax-based Wagners Law Firm, which is also seeking a class action against OrganiGram on similar grounds. Toronto-based law firm Roy O’Connor announced a proposed class action against Mettrum two weeks ago. All three cases are seeking certification by the courts.

The man listed in the new proposed class action claims he became violently ill after consuming medical marijuana purchased from Mettrum.

The Globe and Mail reported that a group of veterans is also amassing a file of evidence detailing illnesses after exposure to tainted products with symptoms that include becoming bedridden, nausea and breathing difficulties.

The banned pesticides in the proposed class actions include myclobutanil and bifenazate, which aren’t approved for use on cannabis and haven’t undergone safety testing for humans.

A court must certify the proposed class-action lawsuits before they can go forward. Canopy Growth Corp., which bought Mettrum at the start of the year, and Organigram have vowed to fight the allegations.

Colorado congressman says he'll “fight the Attorney General” if need be on marijuana

DENVER — Rep. Mike Coffman is suggesting he might use the power of the purse to protect Colorado’s legal marijuana industry.

During a telephone town hall Wednesday evening the Republican congressman was asked about Attorney General Jeff Sessions’ threat to crack down on states like Colorado that have legalized recreational marijuana.

Coffman noted that he opposed the ballot measures that legalized both medical and recreational marijuana in the state. But he added that since voters approved them they are now Colorado law. He said the federal government should not interfere and he hopes Sessions doesn’t follow through on his warning.

If Sessions does take action Coffman said he’d “have to fight the Attorney General on this.” He suggested he’d do so through Congress’ power to appropriate money for the administration’s budget.


Published at Thu, 16 Mar 2017 18:07:06 +0000

Read More

Is Jeff Sessions at odds with President Trump on medical marijuana?

RICHMOND, Va. – Attorney General Jeff Sessions has repeatedly condemned the recreational use of marijuana. On Wednesday he went a step further, casting doubt on medical marijuana use.

Related:Sessions triples down on marijuana as dangerous drug, not opioid crisis solution

“I think medical marijuana has been hyped, maybe too much,” he told reporters after an event addressing violent crime in Richmond. “Dosages can be constructed in a way that might be beneficial, I acknowledge that, but if you smoke marijuana for example, where you have no idea how much THC you’re getting, it’s probably not a good way to administer a medicinal amount. So forgive me if I’m a bit dubious about that.”

Sessions also cast doubt, as he has before, on the use of marijuana to curb opioid addiction.

Studies have shown that medical marijuana laws and access to medical marijuana dispensaries are associated with fewer opioid deaths and less prescription painkiller abuse.

During his campaign, President Donald Trump said he was “100 percent” in favor of medical marijuana. White House spokesman Sean Spicer recently confirmed that the president sees a “big difference” between using marijuana for medical and recreational purposes.

“The problem is that you’re seeing now a disagreement between Sessions and the president on the issue of medical marijuana,” said Michael Collins of the Drug Policy Alliance. “It’s concerning because the administration, the White House themselves have sort of committed themselves to not going after medical marijuana. Sessions is out casting doubt on that.”

Smoking is a necessary way to consume medical marijuana, he said, because chronic pain sufferers need the instantaneous relief other forms of the drug cannot provide. The dosage concern doesn’t make sense, he said, because there’s no evidence of fatal marijuana overdoses.

A congressional provision prevents the Justice Department from spending money to interfere with state-level medical marijuana programs. However, that appropriations amendment must be reauthorized this year. Twenty-eight states, the District of Columbia, Guam and Puerto Rico have medical marijuana programs, according to the National Conference of State Legislatures.

Collins said the federal government could easily do research into marijuana efficacy, but that opponents of legalization are standing in the way.

“The people complaining that more research needs to be done are the very people in a position to do the research,” he said. “But they’ll never do it, because they know the research will show the positives.”

Independent studies have generally found marijuana to be effective for treating chronic pain, nausea and vomiting in cancer patients, and muscle spasticity in multiple sclerosis patients. But the Drug Enforcement Administration, which operates under the Justice Department, maintains that marijuana has no medical value.

Watch: Trump tells Fox News and a rally of supporters how he feels about marijuana. In both, he distinguishes between medical and recreational cannabis:


Published at Wed, 15 Mar 2017 20:24:14 +0000

Read More

Arkansas Senate Rejects Measure to Ban Smoking of Medical Cannabis

An effort by Arkansas lawmakers to undermine a voter-approved initiative that legalizes medical cannabis has failed in the Senate.

In November Arkansas voters approved Issue 6 with 53% voting in favor. The constitutional amendment legalizes the possession and use of medical cannabis, including a system of licensed dispensaries. Today the Senate voted 15 to 11 to reject Senate Bill 357, a measure filed by Representative Jason Rapert (D) that would have made changes to this law, banning the actual smoking of medical cannabis. This is the second time this year the Senate has rejected such a measure.

A motion that would have allowed the bill to come up again at a later time failed unanimously, 11 to 0. This thankfully puts the bill to rest, at least for the time being.

Under Arkansas’ new law the state will begin accepting applications for dispensaries in July, which are expected to be open sometime next year. Those who receive a recommendation from a physician, and register with the state, will be authorized to use these safe access points once they open their doors.

About Anthony Martinelli

Anthony, co-founder and Editor-in-Chief of TheJointBlog, has worked closely with numerous elected officials who support cannabis law reform, including as the former Campaign Manager for Washington State Representative Dave Upthegrove. He has also been published by multiple media outlets, including the Seattle Times. He can be reached at TheJointBlog@TheJointBlog.com.


Published at Tue, 14 Mar 2017 06:10:23 +0000

Read More